Bruce C. Conway
Director/Board Member at Trigemina, Inc.
Bruce C. Conway active positions
| Companies | Position | Start | End |
|---|---|---|---|
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Director/Board Member | - | - |
Career history of Bruce C. Conway
Former positions of Bruce C. Conway
| Companies | Position | Start | End |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Director/Board Member | 2011-04-30 | 2013-04-11 |
| Independent Dir/Board Member | 2011-04-30 | 2013-04-11 | |
Whitehall Corp.
 Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Director/Board Member | - | - |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Whitehall Corp.
Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Electronic Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |
- Stock Market
- Insiders
- Bruce C. Conway
- Experience